Metoclopramide
Indication
Nausea associated with Acute Migraine
MHRA Drug Safety Update - Metoclopramide: risk of neurological adverse effects
Green
Brand:
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Central nervous system
Background
Recommended for Nausea associated with Acute Migraine in line with the Primary Care Adult Headache Management
Pathway
Recommendation
LSCMMG Recommendation:
Green
Reason for decision:
Suitable for initiation in primary care
Supporting documents: